Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

JAMA

Volumn 287, Issue 5, 2002, Pages 591-597

  Hlatky, Mark A ^a   Boothroyd, Derek ^a   Vittinghoff, Eric ^b   Sharp, Penny ^c   Whooley, Mary A ^b,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Department of Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FLUSHING; FOLLOW UP; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENTAL HEALTH; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SECONDARY PREVENTION; THORAX PAIN;

EID: 0037028766     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.5.591     Document Type: Article

References (35)

1. Use of hormone replacement therapy by postmenopausal women in the United States
2. Hormone therapy to prevent disease and prolong life in postmenopausal women
3. Postmenopausal hormone-replacement therapy
4. Design of the Women's Health Initiative clinical trial and observational study
5. Patient-specific decisions about hormone replacement therapy in postmenopausal women
6. Postmenopausal estrogens in prevention of osteoporosis: Benefit virtually without risk if cardiovascular effects are considered
7. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
8. Estrogen replacement therapy and coronary heart disease
9. Breast cancer and hormone replacement therapy
10. Hormone replacement therapy and endometrial cancer risk: A meta-analysis
11. Postmenopausal hormone therapy increases risk for venous thromboembolic disease
12. Postmenopausal hormone therapy and mortality
13. The role of cost-effectiveness analysis in health and medicine
14. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
15. Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics
16. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)
17. The MOS 36-item Short-Form health survey (SF-36), I
18. The MOS Short-Form general health survey: Reliability and validity in a patient population
19. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study
20. Development of a brief screening instrument for detecting depressive disorders
21. Unbalanced repeated measures models with structured covariance matrices
22. Postmenopausal hormone therapy and risk of stroke
23. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease
24. Effects of hormone replacement therapy on clinical fractures and height loss
25. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease
26. Postmenopausal hormones and incontinence
27. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy
28. Quality of life after the menopause
29. Symptom relief and side effects of postmenopausal hormones
30. Linking clinical variables with health-related quality of life
31. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
32. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery
33. The effects of antihypertensive therapy on the quality of life